PeptideDB

Lithium citrate

CAS: 919-16-4 F: C6H5Li3O7 W: 209.92

Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease[1].
Name Lithium citrate
CAS 919-16-4
Formula C6H5Li3O7
Molar Mass 209.92
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Mitra Assadi, et al. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010 Jul;14(4):354-9.